Changes in circulating miRNAs as a prognostic tool for heart failure related morbidity and mortality in patients suffering from stable HFpEF: A subgroup analysis of the ALDO-DHF trial

26 May 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Mr Johannes Petutschnigg

Charite University Hospital, Berlin (Germany)

23 More presentations in this session

Presentation thumbnail

Lung ultrasound in the diagnosis of cardiogenic dyspnea

Doctor T. Valova (Sofia, BG)

Abstract Slides

Presentation thumbnail

Biomarker role of relaxins in myocardial fibrosis and left ventricular diastolic function in ischemic heart failure with reduced ejection fraction

Doctor E. Gara (Budapest, HU)

Presentation thumbnail

Eyes on amyloidosis: Severe microvascular retinal dysfunction in cardiac amyloidosis.

Mr E. Zampiccoli (Zuerich, CH)

Presentation thumbnail

Derivation and validation of a conversion equation between B-type natriuretic peptide and N-terminal pro BNP levels

Mr S. Kasahara (Sendai, JP)

Presentation thumbnail

Prevalence of heart failure with preserved and reduced left ventricular ejection fraction and diagnostic value of MR-proANP in 803 outpatients with type 2 diabetes

Doctor J. Jensen (Copenhagen, DK)

Access the full session

Session thumbnail

Poster Session 3 - Chronic Heart Failure – Diagnostic Methods

The Event

Heart Failure 2018

26 May - 29 May 2018

You may be interested in

Congress Presentation

The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure

Congress Session

From genetic signatures to clinical implications

Congress Presentation

Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources